Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 73 (PPIAP73) is a processed pseudogene related to the peptidylprolyl isomerase A (PPIA or cyclophilin A) gene[1]. Unlike its parental gene, PPIAP73 does not encode a functional protein and has no known direct biological or pathological role. Pseudogenes like PPIAP73 may sometimes regulate gene expression through non-coding RNA mechanisms, as described for other PPIA pseudogenes, but there is no evidence for such a role for PPIAP73 itself[1][2][4]. Therefore, PPIAP73 is not considered a drug target, biomarker, or clinically relevant molecule. Key note: PPIAP73 should not be confused with functional peptidylprolyl isomerase A (PPIA/cyclophilin A), which is an enzyme implicated in protein folding, immunoregulation, and disease and is sometimes targeted by drugs like cyclosporine[6]. However, PPIAP73 itself does not share these properties, and current biomedical databases list no disease nor pharmacological relevance for this pseudogene[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 73 (PPIAP73).